Approaches to manage ‘affordability’ of high budget impact medicines in key EU countries

Background: The launch of hepatitis C (HCV) drugs such as sofosbuvir or ledipasvir has fostered the question of affordability of novel high budget impact therapies even in countries with high domestic product. European countries have developed a variety of mechanisms to improve affordability of such...

Descripción completa

Detalles Bibliográficos
Autores principales: Flume, Mathias, Bardou, Marc, Capri, Stefano, Sola-Morales, Oriol, Cunningham, David, Levin, Lars-Ake, Postma, Maarten J., Touchot, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Routledge 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998770/
https://www.ncbi.nlm.nih.gov/pubmed/29915664
http://dx.doi.org/10.1080/20016689.2018.1478539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998770/
https://www.ncbi.nlm.nih.gov/pubmed/29915664
http://dx.doi.org/10.1080/20016689.2018.1478539

Ejemplares similares